Prevalence of alpha-papillomavirus genotypes in cervical squamous intraepithelial lesions and invasive cervical carcinoma in the italian population

Journal of Medical Virology

Volumn 78, Issue 12, 2006, Pages 1663-1672

  Tornesello, Maria Lina ^a,b   Duraturo, Maria Luisa ^a,b   Botti, Gerardo ^a,b   Greggi, Stefano ^a,b   Piccoli, Roberto ^b   De Palo, Giuseppe ^c,e   Montella, Maurizio ^a,b   Buonaguro, Luigi ^a,b   Buonaguro, Franco M ^a,b   Stellato, G ^b   Losito, S ^b   Pilotti, S ^d   Stefanon, B ^e   Monaco, R ^f   Tramontana, R ^g   Tramontana, S ^g   Lillo, F ^h   Uberti Foppa, C ^h   Lazzarin, A ^h   Vallefuoco, G ⁱ   Palmieri, S ⁱ   more..

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d 1st Naz Tumori   (Italy)

^e 1st Naz Tumori   (Italy)

^f CARDARELLI HOSPITAL   (Italy)

^g Gynecology Unit of Villa Stabia Clinic

^h SAN RAFFAELE HOSPITAL   (Italy)

ⁱ Clinica Pineta Grande   (Italy)

Author keywords

Cervical carcinoma; Cervical intraepithelial neoplasia; HPV genotypes; Italy

Indexed keywords

ADULT; ALPHA PAPILLOMAVIRUS; ARTICLE; CANCER RISK; CONSENSUS SEQUENCE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 82; HUMAN TISSUE; INFECTION RATE; INFECTION RISK; INVASIVE CARCINOMA; ITALY; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; SEQUENCE ANALYSIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS IDENTIFICATION; VIRUS INFECTION; WART VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENOTYPE; HUMANS; ITALY; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; SEQUENCE ANALYSIS, DNA; SPECIES SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 33750551908     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20752     Document Type: Article

References (43)

1. Baumgarth N, Szubin R, Dolganov GM, Watnik MR, Greenspan D, Da Costa M, Palefsky JM, Jordan R, Roederer M, Greenspan JS. 2004. Highly tissue substructure-specific effects of human papilloma virus in mucosa of HIV-infected patients revealed by laser-dissection microscopy-assisted gene expression profiling. Am J Pathol 165:707-718.
2. Beaudenon S, Praetorius F, Kremsdorf D, Lutzner M, Worsaae N, Pehau-Arnaudet G, Orth G. 1987. A new type of human papillomavirus associated with oral focal epithelial hyperplasia. J Invest Dermatol 88:130-135.
3. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM. 1994. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170:1077-1085.
4. Bosch FX, de Sanjose S. 2003. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr. 31:3-13.
5. Buonaguro FM, Tornesello ML, Beth-Giraldo E, Hatzakis A, Mueller N, Downing R, Biryamwaho B, Sempala SD, Giraldo G. 1996. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer 65:25-28.
6. Buonaguro FM, Tornesello ML, Salatiello I, Okong P, Buonaguro L, Beth-Giraldo E, Biryahwaho B, Sempala SD, Giraldo G. 2000. The Uganda study on HPV variants and genital cancers. J Clin Virol 19:31-41.
7. Chan PK, Cheung TH, Tam AO, Lo KW, Yim SF, Yu MM, To KF, Wong YF, Cheung JL, Chan DP, Hui M, Ip M. 2006. Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int J Cancer 118:243-245.
8. Clifford GM, Smith JS, Aguado T, Franceschi S. 2003a. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 89:101-105.
9. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. 2003b. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 88:63-73.
10. Clifford GM, Callus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Mates E, Molano M, Rajkumar R, Ronco G, de Sanjose S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S; IARC HPV Prevalence Surveys Study Group. 2005a. Worldwide distribution of, human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet 366:991-998.
11. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. 2005b. Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 14:1157-1164.
12. De Francesco MA, Gargiulo F, Schreiber C, Ciravolo G, Salinaro F, Manca N. 2005. Detection and genotyping of human papillomavirus in cervical samples from Italian patients. J Med Virol 75:588-592.
13. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. 1995. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057-1062.
14. de Villiers EM, Neumann C, Le JY, Weidauer H, zur Hausen H. 1986. Infection of the oral mucosa with denned types of human papillomaviruses. Med Microbiol Immunol (Berl) 174:287-294.
15. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
16. Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, Vaccarella SV Jara AT, Puschel KI, Robles SC, Herrero R, Franceschi SF, Ojeda JM. 2004. Related Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 13:2271-2276.
17. Franceschi S, Rajkumar R, Snijders PJ, Arslan A, Mahe C, Plummer M, Sankaranarayanan R, Cherian J, Meijer CJ, Weiderpass E. 2005. Papillomavirus infection in rural women in southern India. Br J Cancer 92:601-606.
18. Fredricks DN, Relman DA. 1999. Paraffin removal from tissue sections for digestion and PCR analysis. Biotechniques 26:198-200.
19. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, Dubin G; GlaxoSmithKline HPV Vaccine Study Group. 2004. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial. Lancet 364:1757-1765.
20. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G; HPV Vaccine Study group. 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial. Lancet 367:1247-1255.
21. Ho GY, Studentsov Y, Hall CB, Bierman R, Beardsley L, Lempa M, Burk RD. 2002. Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles. J Infect Dis 186:737-742.
22. Ho GY, Studentsov YY, Bierman R, Burk RD. 2004. Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol Biomarkers Prev 13:110-116.
23. Husnjak K, Grce M, Magdic L, Pavelic K. 2000. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J Virol Methods. 88:125-134.
24. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. 1994. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 86:494-499.
25. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU; Proof of Principle Study Investigators. 2002. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347:1645-1651.
26. Lavergne D, de Villiers EM. 1999. Papillomavirus in esophageal papillomas and carcinomas. Int J Cancer 80:681-684.
27. Munoz N. 2000. Human papillomavirus and cancer: The epidemiological evidence. J Clin Virol 19:1-5.
28. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527.
29. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD. 1997. PCR detection of human papillomavirus: Comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35:1304-1310.
30. Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J, Manos MM. 1990. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 82:1477-1484.
31. Ronco G, Ghisetti V, Segnan N, Snijders PJ, Gillio-Tos A, Meijer CJ, Merletti F, Franceschi S. 2005. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 41:297-305.
32. Sasagawa T, Yamazaki H, Dong YZ, Satake S, Tateno M, Inoue M. 1998. Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions. Int J Cancer 75:529-535.
33. Terai M, Burk RD. 2001. Characterization of a novel genital human papillomavirus by overlapping PCR: Candhpv86 identified in cervicovaginal cells of a woman with cervical neoplasia. J Gen Virol 82:2035-2040.
34. Terai M, Burk RD. 2002. Identification and characterization of 3 novel genital human papillomaviruses by overlapping polymerase chain reaction: Candhpv89, candHPV90, and candHPV91. J Infect Dis 185:1794-1797.
35. Tornesello ML, Buonaguro FM, Meglio A, Buonaguro L, Beth-Giraldo E, Giraldo G. 1997. Sequence variations and viral genomic state of human papillomavirus type 16 in penile carcinomas from Ugandan patients. J Gen Virol 78:2199-2208.
36. Tornesello ML, Buonaguro FM, Buonaguro L, Salatiello I, Beth-Giraldo E, Giraldo G. 2000. Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas. J Gen Virol 81:2969-2982.
37. Tornesello ML, Duraturo ML, Salatiello I, Buonaguro L, Losito S, Botti G, Stellato G, Greggi S, Piccoli R, Pilotti S, Stefanon B, De Palo G, Franceschi S, Buonaguro FM. 2004. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol 74:117-126.
38. Tornesello ML, Duraturo ML, Buonaguro L, De Falco C, Vallefuoco G, Piccoli R, Palmieri S, Buonaguro FM. 2006. Heterogeneous distribution of human papillomavirus genotypes in high risk West Africa women immigrants in South Italy. 6th International multidisciplinary congress Eurogin 2006-Paris, April 23-26:71.
39. Van Ranst M, Kaplan JB, Burk RD. 1992. Phylogenetic classification of human papillomaviruses: Correlation with clinical manifestations. J Gen Virol 73:2653-2660.
40. Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, Skjeldestad FE, Olsson SE, Steinwall M, Brown DR, Kurman RJ, Ronnett BM, Stoler MH, Ferenczy A, Harper DM, Tamms GM, Yu J, Lupinacci L, Railkar R, Taddeo FJ, Jansen KU, Esser MT, Sings HL, Saah AJ, Barr E. 2005. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 6:271-278.
41. Winship PR. 1989. An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucleic acids Res 17:1266-1266.
42. Zerbini M, Venturoli S, Cricca M, Gallinella G, De Simone P, Costa S, Santini D, Musiani M. 2001. Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCR-ELISA. J Clin Pathol 54:377-380.
43. zur Hausen H. 2000. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92:690-698.